Non-invasive light therapy for autism symptoms
Social and Behavioral Associations With Prefrontal Photobiomodulation in Autism Spectrum
This study is testing whether a new light therapy can help improve thinking and behavior in people with autism.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 280 (estimated) |
| Ages | 4 Years to 60 Years |
| Sex | All |
| Sponsor | University of Texas at Austin Academic / other |
| Locations | 1 site (Austin, Texas) |
| Trial ID | NCT06203938 on ClinicalTrials.gov |
What this trial studies
This study investigates the effects of transcranial infrared light stimulation (TILS) on individuals diagnosed with autism spectrum disorder (ASD). The researchers at the University of Texas at Austin aim to determine whether this non-invasive therapy can improve cognitive functions and behavioral symptoms associated with ASD. TILS targets cytochrome c oxidase, a key enzyme involved in mitochondrial function, which is often impaired in individuals with ASD. The study will recruit participants aged 4 to 60 years, including both those with ASD and those without, to assess the potential benefits of repeated TILS administration.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals aged 4 to 60 years diagnosed with autism spectrum disorder.
Not a fit: Patients who are currently pregnant will not benefit from this study.
Why it matters
Potential benefit: If successful, this therapy could lead to improved cognitive and emotional functioning in individuals with autism spectrum disorder.
How similar studies have performed: Previous studies have shown promising results with similar approaches, indicating potential for success in this novel application.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age between 4-60 years Exclusion Criteria: * Current pregnancy
Where this trial is running
Austin, Texas
- Seay Psychology Building, Room 3.304 — Austin, Texas, United States (Recruiting)
Study contacts
- Study coordinator: Francisco Gonzalez-Lima, PhD
- Email: UTAutismExperiment@gmail.com
- Phone: 512-537-5257
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.